A novel role of renin inhibitor in the complement cascade
- PMID: 30243307
- DOI: 10.1016/j.kint.2018.05.025
A novel role of renin inhibitor in the complement cascade
Abstract
Aberrant regulation of an alternative pathway of the complement system could be a therapeutic target of C3 glomerulopathy, including dense deposit disease. In the current issue, Békássy and colleagues provide data on enzymatic conversion of C3 by renin in vitro and on the efficacy of a direct renin inhibitor, aliskiren, on systemic and renal complement activation in patients with dense deposit disease.
Copyright © 2018 International Society of Nephrology. All rights reserved.
Comment on
-
Aliskiren inhibits renin-mediated complement activation.Kidney Int. 2018 Oct;94(4):689-700. doi: 10.1016/j.kint.2018.04.004. Epub 2018 Jun 5. Kidney Int. 2018. PMID: 29884545
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous